770 related articles for article (PubMed ID: 18480417)
1. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
[TBL] [Abstract][Full Text] [Related]
2. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW
J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
[TBL] [Abstract][Full Text] [Related]
3. Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats.
Braun C; Lüdicke C; Rebsch W; Gretz N; van der Woude FJ; Rohmeiss P
Nephrol Dial Transplant; 1996; 11 Suppl 6():52-7. PubMed ID: 9044329
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
5. Progression of renal failure in the Han: SPRD polycystic kidney rat.
Zeier M; Pohlmeyer G; Deerberg F; Schönherr R; Ritz E
Nephrol Dial Transplant; 1994; 9(12):1734-9. PubMed ID: 7708256
[TBL] [Abstract][Full Text] [Related]
6. Hypertension and renal injury in experimental polycystic kidney disease.
Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
Lawson CR; Doulton TW; MacGregor GA
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.
Tao Y; Kim J; Schrier RW; Edelstein CL
J Am Soc Nephrol; 2005 Jan; 16(1):46-51. PubMed ID: 15563559
[TBL] [Abstract][Full Text] [Related]
9. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
[TBL] [Abstract][Full Text] [Related]
10. Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease.
Phillips JK; Hopwood D; Loxley RA; Ghatora K; Coombes JD; Tan YS; Harrison JL; McKitrick DJ; Holobotvskyy V; Arnolda LF; Rangan GK
Kidney Blood Press Res; 2007; 30(3):129-44. PubMed ID: 17446713
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
[TBL] [Abstract][Full Text] [Related]
12. Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model.
Zafar I; Tao Y; Falk S; McFann K; Schrier RW; Edelstein CL
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F854-9. PubMed ID: 17581927
[TBL] [Abstract][Full Text] [Related]
13. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J
Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161
[TBL] [Abstract][Full Text] [Related]
14. Renal hypertension in rats with hereditary polycystic kidney disease.
Kaspareit-Rittinghausen J; Deerberg F; Rapp KG; Wcislo A
Z Versuchstierkd; 1990; 33(5):201-4. PubMed ID: 2267865
[TBL] [Abstract][Full Text] [Related]
15. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
Masoumi A; Elhassan E; Schrier RW
Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
[TBL] [Abstract][Full Text] [Related]
16. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
Cowley BD; Rupp JC; Muessel MJ; Gattone VH
Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
[TBL] [Abstract][Full Text] [Related]
17. Gender hormones and the progression of experimental polycystic kidney disease.
Stringer KD; Komers R; Osman SA; Oyama TT; Lindsley JN; Anderson S
Kidney Int; 2005 Oct; 68(4):1729-39. PubMed ID: 16164649
[TBL] [Abstract][Full Text] [Related]
18. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Ecder T; Schrier RW
Expert Rev Cardiovasc Ther; 2004 May; 2(3):369-74. PubMed ID: 15151483
[TBL] [Abstract][Full Text] [Related]
19. [The relation of hypertension, renal function and cardiovascular events in autosomal dominant polycystic kidney disease].
Idrizi A; Barbullushi M; Strakosha A; Kodra S; Thereska N; Zaimi E; Gjyzari A; Petrela E
G Ital Nefrol; 2007; 24(6):595-9. PubMed ID: 18278763
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
